Effect of Phenol Addition to Laser Treatment on Epithelialization and Healing Process in Pilonidal Sinus
PLEPS
1 other identifier
interventional
130
1 country
1
Brief Summary
This study compares two treatment approaches for pilonidal sinus disease: laser treatment alone versus laser treatment combined with phenol application. Pilonidal sinus is a common condition that affects young adults and can cause significant discomfort and time off work. Participants will be randomly assigned to receive either laser treatment only (Group A) or laser treatment plus phenol application (Group B). Both treatments are minimally invasive and performed under local anesthesia as day surgery procedures. The main goal is to determine if adding phenol to laser treatment speeds up the healing process (epithelialization) and improves patient outcomes. We will measure healing time, pain levels, return to daily activities, and quality of life over a 3-month follow-up period. This research may help develop more effective treatment protocols that reduce healing time and improve patient comfort for people with pilonidal sinus disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2025
CompletedFirst Submitted
Initial submission to the registry
June 8, 2025
CompletedFirst Posted
Study publicly available on registry
June 17, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2025
CompletedJune 17, 2025
June 1, 2025
4 months
June 8, 2025
June 14, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Time to Complete Epithelialization
Time required for complete epithelialization of the pilonidal sinus wound, assessed by clinical examination during follow-up visits. Complete epithelialization is defined as full closure of the wound with healthy epithelial tissue covering the entire treated area.
From date of surgery until complete epithelialization is achieved, assessed up to 3 months
Secondary Outcomes (4)
Postoperative Pain Scores
Measured at 2 weeks, 4 weeks, and 3 months post-surgery
Return to Daily Activities Time
From date of surgery until return to normal activities, assessed up to 3 months
Complication Rate
From surgery through 3 months follow-up
Patient Satisfaction- VAS score Patient Satisfaction Patient Satisfaction
At 3 months post-surgery
Study Arms (2)
Laser Treatment Only
ACTIVE COMPARATORParticipants receive laser treatment (SiLaC - Sinus Laser Closure) under local anesthesia. The pilonidal sinus area is cleaned, sinus openings are evaluated, and laser probe is inserted into sinus channels for ablation. Standard post-operative wound care is provided with same-day discharge.
Crystallized Phenol
EXPERIMENTALParticipants receive combined treatment under local anesthesia. First, the pilonidal sinus area is cleaned and curetted, then crystallized phenol is applied into sinus channels. After a specified time, phenol is neutralized with normal saline, followed by laser treatment (SiLaC) application. Standard post-operative wound care is provided with same-day discharge.
Interventions
Minimally invasive laser ablation procedure performed under local anesthesia for pilonidal sinus treatment. Laser energy is delivered through a fiber optic probe inserted into the sinus tract to achieve thermal ablation of the sinus cavity.
rystallized phenol is applied directly into the pilonidal sinus channels after cleaning and curettage. The phenol remains in contact for a specified duration before being neutralized with normal saline irrigation.
Eligibility Criteria
You may qualify if:
- Age 18 years and older
- Primary pilonidal sinus disease
- Three or fewer pit counts
- Willing to participate in the study and signed informed consent form
- Able to attend follow-up visits
You may not qualify if:
- Age under 18 years
- More than three pit counts
- Acute abscess presentation
- Bilateral lateral extension
- Recurrent pilonidal sinus disease
- Immunocompromised patients
- Patients unable to attend follow-up visits
- Pregnancy (if applicable)
- Severe comorbidities that contraindicate surgery under local anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sancaktepe Sehit Prof. Dr. Ilhan Varank Training and Research Hospital
Istanbul, Other, 34785, Turkey (Türkiye)
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Open-label study due to the nature of surgical interventions which cannot be blinded to participants or care providers
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 8, 2025
First Posted
June 17, 2025
Study Start
May 1, 2025
Primary Completion
September 1, 2025
Study Completion
November 1, 2025
Last Updated
June 17, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share